BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 21801380)

  • 1. Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer.
    Pellacani D; Packer RJ; Frame FM; Oldridge EE; Berry PA; Labarthe MC; Stower MJ; Simms MS; Collins AT; Maitland NJ
    Mol Cancer; 2011 Jul; 10():94. PubMed ID: 21801380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
    Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
    Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
    Williamson SC; Hepburn AC; Wilson L; Coffey K; Ryan-Munden CA; Pal D; Leung HY; Robson CN; Heer R
    PLoS One; 2012; 7(11):e48944. PubMed ID: 23145034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation.
    Gopisetty G; Xu J; Sampath D; Colman H; Puduvalli VK
    Oncogene; 2013 Jun; 32(26):3119-29. PubMed ID: 22945648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors.
    Yi JM; Tsai HC; Glöckner SC; Lin S; Ohm JE; Easwaran H; James CD; Costello JF; Riggins G; Eberhart CG; Laterra J; Vescovi AL; Ahuja N; Herman JG; Schuebel KE; Baylin SB
    Cancer Res; 2008 Oct; 68(19):8094-103. PubMed ID: 18829568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation and loss of CD133 gene expression in colorectal cancers.
    Jeon YK; Kim SH; Choi SH; Kim KH; Yoo BC; Ku JL; Park JG
    World J Gastroenterol; 2010 Jul; 16(25):3153-60. PubMed ID: 20593500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression profiling of CD133+ and CD133- epithelial cells from human prostate.
    Shepherd CJ; Rizzo S; Ledaki I; Davies M; Brewer D; Attard G; de Bono J; Hudson DL
    Prostate; 2008 Jun; 68(9):1007-24. PubMed ID: 18398820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-translational modulation of CD133 expression during sodium butyrate-induced differentiation of HT29 human colon cancer cells: implications for its detection.
    Sgambato A; Puglisi MA; Errico F; Rafanelli F; Boninsegna A; Rettino A; Genovese G; Coco C; Gasbarrini A; Cittadini A
    J Cell Physiol; 2010 Jul; 224(1):234-41. PubMed ID: 20333645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
    Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
    Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells.
    Friel AM; Zhang L; Curley MD; Therrien VA; Sergent PA; Belden SE; Borger DR; Mohapatra G; Zukerberg LR; Foster R; Rueda BR
    Reprod Biol Endocrinol; 2010 Dec; 8():147. PubMed ID: 21122138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
    Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
    Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and limitations of lentivirus vectors as tools for tracking differentiation in prostate epithelial cells.
    Frame FM; Hager S; Pellacani D; Stower MJ; Walker HF; Burns JE; Collins AT; Maitland NJ
    Exp Cell Res; 2010 Nov; 316(19):3161-71. PubMed ID: 20727882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations.
    Brown MD; Gilmore PE; Hart CA; Samuel JD; Ramani VA; George NJ; Clarke NW
    Prostate; 2007 Sep; 67(13):1384-96. PubMed ID: 17639507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status.
    Taylor RA; Toivanen R; Frydenberg M; Pedersen J; Harewood L; ; Collins AT; Maitland NJ; Risbridger GP
    Stem Cells; 2012 Jun; 30(6):1087-96. PubMed ID: 22593016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations.
    Yang Z; Zhang L; Ma A; Liu L; Li J; Gu J; Liu Y
    PLoS One; 2011; 6(12):e28405. PubMed ID: 22145042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks.
    Tabu K; Kimura T; Sasai K; Wang L; Bizen N; Nishihara H; Taga T; Tanaka S
    Mol Cancer; 2010 Feb; 9():39. PubMed ID: 20167130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem-like cells in human prostate carcinoma cells DU145: the seeds of the cell line?
    Wei C; Guomin W; Yujun L; Ruizhe Q
    Cancer Biol Ther; 2007 May; 6(5):763-8. PubMed ID: 17592251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer.
    Henrique R; Oliveira AI; Costa VL; Baptista T; Martins AT; Morais A; Oliveira J; Jerónimo C
    BMC Genomics; 2013 Dec; 14():898. PubMed ID: 24344919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
    Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
    J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CD133 in normal human prostate stem cells and malignant cancer-initiating cells.
    Vander Griend DJ; Karthaus WL; Dalrymple S; Meeker A; DeMarzo AM; Isaacs JT
    Cancer Res; 2008 Dec; 68(23):9703-11. PubMed ID: 19047148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.